Epitopes based drug design for dengue virus envelope protein: A computational approach

Area of Science:

• Virology
• Drug Discovery
• Computational Chemistry

Background:

• Dengue virus (DENV) is a widespread epidemic with no approved antiviral drugs.
• The DENV envelope protein is crucial for viral entry into host cells.
• Targeting viral proteins offers a promising strategy for antiviral development.

Purpose of the Study:

• To identify potential drug targets within the dengue envelope protein.
• To develop an in silico approach for discovering novel dengue antiviral agents.
• To screen chemical libraries for compounds that inhibit DENV envelope protein function.

Main Methods:

• In silico identification of conserved B and T cell epitopes in the DENV envelope protein.
• Development of a pharmacophore model based on epitope-receptor interactions (TIM-1).
• Virtual screening of the Chembridge dataset using the pharmacophore model, followed by Lipinski's rule of five filtering and molecular docking.

Main Results:

• A conserved epitope region "QHGTI" was identified and validated through interaction with the TIM-1 receptor.
• Virtual screening yielded 1010 potential compounds, reduced to 442 by Lipinski's rule.
• Molecular docking identified 14 structurally diverse lead candidates with interactions at the DENV envelope glycoprotein active site.

Conclusions:

• The identified lead candidates show potential for developing novel dengue antiviral drugs.
• The in silico approach provides a foundation for further drug development efforts against DENV.
• Targeting the dengue envelope protein is a viable strategy for combating dengue fever.